Berkeley Heights, NJ Hybrid Employment $130,000 - $200,000 USD

Tonix Pharmaceuticals is hiring a Director, Regulatory Affairs - Infectious Disease

Responsibilities

  • Serve as Regulatory Lead for biologics, focused on infectious diseases programs.
  • Develop and execute global regulatory strategies across nonclinical, CMC, and clinical development.
  • Lead preparation, authorship, and coordination of regulatory submissions, including pre‑IND packages, INDs, amendments, and briefing documents.
  • Direct interactions with FDA and other health authorities; prepare teams, lead discussions, and manage responses to queries.
  • Lead cross-functional regulatory efforts by partnering with nonclinical, CMC, clinical, project management, and external partners/CROs.
  • Assess regulatory risks, impacts, and mitigation options; communicate recommendations to internal teams and senior leadership.
  • Ensure compliance with FDA, ICH, and global regulatory requirements, as well as internal SOPs and GxP standards.
  • Oversee regulatory documentation quality and timely delivery of program milestones.

Work Arrangement

Hybrid

Team

Structure: Cross-functional leadership role partnering with nonclinical, CMC, clinical, project management, and external partners/CROs

Need to work legally in Thailand?

Work permits without the paperwork nightmare

Thai immigration rules are strict and easy to get wrong. SVBL handles the bureaucracy — correct visa type, proper documentation, timely submissions. You focus on your work.

Right visa type for your situation
Document preparation & submission
Deadline tracking & renewals
Direct liaison with immigration
Talk to an expert
10+ years experience
About company
Tonix Pharmaceuticals
Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti-Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease.
All jobs at Tonix Pharmaceuticals Visit website
Job Details
Department Regulatory Affairs
Category management
Posted 3 hours ago